Development of a pharmacodynamic biomarker to measure target engagement from inhibition of the NGF-TrkA pathway.

Journal of Neuroscience Methods(2017)

引用 2|浏览17
暂无评分
摘要
•Optimized skin and brain protein extraction methods.•Development of custom rodent and human phospho-Trk ELISA assays.•Determination of TrkA target engagement correlated with efficacy in a preclinical rodent model of pain.•Pilot work for translation to clinical use in human skin biopsies.
更多
查看译文
关键词
TrkA (tropomyosin receptor kinase),NGF (nerve growth factor),Pharmacodynamic biomarker,Rodent pain model,Neurotrophin,Enzyme-linked immunosorbent assays (ELISAs)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要